Pharmaceutical Business review

Sun Pharma generic BPH drug gets FDA approval

Sun Pharma’s alfuzosin hydrochloride extended release tablets are the generic version of Sanofi-aventis’ Uroxatral extended release tablets.

Uroxatral is approved to treat signs and symptoms of benign prostatic hyperplasia (BPH) also known as enlarged prostate.

Uroxatral relaxes the muscles in the prostate and bladder neck, making it easier to urinate.